Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 2Prostatic Neoplasms 1Prostate Lesions 1Oligodendroglioma 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 3Magnetic Resonance Spectroscopy 3Radiotherapy 2Radiation 2Carmustine 2Carboplatin 2pazopanib 1gallium Ga 68 dotatate 1ficlatuzumab 1cabazitaxel 1Triiodothyronine 1TIC10 compound 1Sunitinib 1Sorafenib 1Procarbazine 1O(6)-benzylguanine 1Nivolumab 1Methimazole 1Magnetic Resonance Imaging 1Lomustine 1Isotretinoin 1Irinotecan 1Gadolinium DTPA 1Filgrastim 1Biopsy 1Axitinib 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Gliosarcoma × Magnetic Resonance Imaging × Clear all
NCT00433472 2015-07-29

MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Withdrawn
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡